Skip to content
ClinCalc Pro
Menu
Compound Analgesic (Paracetamol + Codeine)

Co-codamol 30/500

Brand names: Kapake, Solpadol, Tylex

Co-codamol 30/500 is a fixed-dose combination of codeine phosphate and paracetamol used for moderate musculoskeletal and post-operative orthopaedic pain not relieved by paracetamol alone. The 30/500 strength delivers the higher codeine content within the combination tablet.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

Codeine is a weak opioid that is metabolised to morphine to act on mu-opioid receptors, while paracetamol provides central analgesic and antipyretic action through poorly understood central mechanisms; together they give additive analgesia.

Prescribing in practice

  • Because the tablet contains paracetamol, warn against taking any additional paracetamol-containing products to avoid inadvertent overdose and hepatotoxicity, and never exceed the stated maximum tablets in 24 hours.
  • Codeine is converted to morphine by CYP2D6 and effect varies with metaboliser status — ultra-rapid metabolisers risk opioid toxicity, so it is contraindicated in breastfeeding and avoided in children, while interacting CYP2D6 inhibitors and other CNS depressants increase risk.
  • Use for the shortest effective period, anticipate constipation and the potential for dependence, and reduce dose or avoid in significant renal or hepatic impairment per the SPC.

Monitoring

Monitor pain control, bowel function, and signs of opioid sedation or excessive use, and reassess the need to continue at each review.

Counselling the patient

  • Do not take any other medicine containing paracetamol at the same time.
  • Expect possible constipation and drowsiness; do not drive if affected, and do not drink alcohol.
  • Take it only as needed for short-term pain and seek advice before stopping a regular course to avoid withdrawal.

Evidence & guidelines

NICE guidance supports short-term, lowest-effective-dose opioid-containing analgesia for acute pain and cautions against routine long-term use.

Reference: NICE NG59; WHO Analgesic Ladder; MHRA Drug Safety Update (codeine in children, 2013); Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.